福安药业(300194.SZ)发布前三季度业绩，归母净利润1.66亿元，下降44.87%

Core Viewpoint - Fuan Pharmaceutical (300194.SZ) reported a significant decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first three quarters was 1.315 billion yuan, representing a year-on-year decrease of 34.08% [1] - The net profit attributable to shareholders of the listed company was 166 million yuan, down 44.87% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 148 million yuan, a decrease of 47.53% year-on-year [1] - Basic earnings per share were reported at 0.14 yuan [1]